A carregar...

Drug rechanneling: a novel paradigm for cancer treatment

Cancer continues to be one of the leading contributors towards global disease burden. According to NIH, cancer incidence rate per year will increase to 23.6 million by 2030. Even though cancer continues to be a major proportion of the disease burden worldwide, it has the lowest clinical trial succes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Semin Cancer Biol
Main Authors: Kaushik, Itishree, Ramachandran, Sharavan, Prasad, Sahdeo, Srivastava, Sanjay K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7786449/
https://ncbi.nlm.nih.gov/pubmed/32437876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2020.03.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!